Sinus surgery gel nears market:
This article was originally published in Clinica
Executive Summary
US company Biomatrix has submitted its 510(k) premarket clearance application to the FDA for Hylasine, an adhesion prevention product used in sinus surgery. The Ridgefield, New Jersey-based company said the gel can be used during and after surgery to coat the surgically altered tissue to stop bleeding and reduce scarring and adhesions. Around 300,000 sinus surgeries are performed each year in the US.